Net profit of Morepen Laboratories declined 28.15% to Rs 20.32 crore in the quarter ended March 2025 as against Rs 28.28 crore during the previous quarter ended March 2024. Sales rose 10.11% to Rs 465.85 crore in the quarter ended March 2025 as against Rs 423.07 crore during the previous quarter ended March 2024.
For the full year,net profit rose 22.73% to Rs 118.02 crore in the year ended March 2025 as against Rs 96.16 crore during the previous year ended March 2024. Sales rose 7.17% to Rs 1811.58 crore in the year ended March 2025 as against Rs 1690.43 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 465.85 | 423.07 | 10 | 1811.58 | 1690.43 | 7 |
| OPM % | 9.07 | 11.44 | - | 9.61 | 9.38 | - |
| PBDT | 42.18 | 51.83 | -19 | 184.09 | 168.89 | 9 |
| PBT | 25.71 | 42.20 | -39 | 155.11 | 135.42 | 15 |
| NP | 20.32 | 28.28 | -28 | 118.02 | 96.16 | 23 |